nps-568 has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bekeredjian, R; Gross, ML; Koleganova, N; Piecha, G; Ritz, E; Schirmacher, P; Schmitt, CP | 1 |
| Chen, NX; Duan, D; Gattone, VH; Henley, C; Martin, D; Moe, SM; Seifert, MF; Sinders, RM | 1 |
| Fox, J; Furuya, Y; Ishii, H; Nagano, N; Nemeth, EF; Wada, M | 1 |
3 other study(ies) available for nps-568 and Cirrhosis
| Article | Year |
|---|---|
Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimetic.
Topics: Aniline Compounds; Animals; Biomarkers; Calcium; Capillaries; Coronary Vessels; Endothelium, Vascular; Enzyme Activation; Fibrosis; Heart; Heart Diseases; Male; Mitogen-Activated Protein Kinases; Myocardial Contraction; Myocardium; Nephrectomy; Organ Size; Oxidative Stress; Phenethylamines; Phosphorus; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Uremia | 2009 |
Calcimimetic inhibits late-stage cyst growth in ADPKD.
Topics: Aniline Compounds; Animals; Calcium; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fibrosis; Hyperparathyroidism; Kidney; Male; Parathyroid Hormone; Phenethylamines; Polycystic Kidney Diseases; Propylamines; Rats; Rats, Inbred Strains; Receptors, Calcium-Sensing; Severity of Illness Index | 2009 |
NPS R-568 halts or reverses osteitis fibrosa in uremic rats.
Topics: Aniline Compounds; Animals; Biomechanical Phenomena; Bone Density; Calcium; Creatinine; Femur; Fibrosis; Hyperparathyroidism; Kidney Function Tests; Male; Osteitis; Parathyroid Hormone; Phenethylamines; Propylamines; Radiography; Rats; Rats, Sprague-Dawley; Tibia; Uremia | 1998 |